ADRs End Lower; AstraZeneca, Can-Fite BioPharma Trade Actively

01/24/2023 | 05:48pm

By Denny Jacob

International stocks trading in New York closed lower on Tuesday.

The S&P/BNY Mellon index of American depositary receipts edged down 0.3% to 155.25. The European index ticked down 0.7% to 146.31. The Asian index moved down 0.1% to 187.51. The Latin American index gained 1.5% to 198.52, while the emerging-markets index was virtually unchanged at 317.05.

AstraZeneca PLC was among those whose ADRs traded actively. The pharmaceutical giant moved down 2% following a collaboration with Thermo Fisher Scientific Inc. to develop a solid tissue and blood-based companion diagnostic test for tagrisso, part of a multi-year agreement.

Can-Fite BioPharma Ltd. slipped 6.3% after the biotechnology company said it filed a patent application that covers the use of namodenoson for the treatment of pancreatic cancer after announcing the anti-cancer drug significantly inhibits the growth of pancreatic carcinoma as a stand-alone treatment.

Write to Denny Jacob at

(END) Dow Jones Newswires

01-24-23 1747ET

Copier lien
Latest news about ""
5h ago
5h ago
10h ago
14h ago
14h ago